Hannover Rück SE (BIT:1HANN)

Market Cap	30.92B
Revenue (ttm)	29.44B
Net Income (ttm)	2.48B
Shares Out	n/a
EPS (ttm)	20.58
PE Ratio	12.46
Forward PE	11.73
Dividend	9.00 (3.32%)
Ex-Dividend Date	May 8, 2025

Volume	n/a
Average Volume	4
Open	271.20
Previous Close	271.20
Day's Range	271.20 - 271.20
52-Week Range	242.20 - 288.00
Beta	n/a
RSI	59.87
Earnings Date	Aug 12, 2025

About Ligand Pharmaceuticals

Hannover Rück SE, together with its subsidiaries, provides reinsurance products and services in Germany, the United Kingdom, France, Europe, the United States, Asia, Australia, Africa, and internationally. It operates through Property & Casualty Reinsurance; and Life & Health Reinsurance segments. The company provides property and casualty reinsurance solutions for agricultural, livestock, and bloodstock; aviation and space; natural catastrophe; credit, surety, and political risks; cyber; facultative; and marine and offshore energy businesses, ...

• Industry: Life Insurance
• Founded: 1966
• Employees: 3,895
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1HANN

Financial Performance

In 2024, Hannover Rück SE's revenue was 26.46 billion, an increase of 2.86% compared to the previous year's 25.72 billion. Earnings were 2.33 billion, an increase of 27.61%.